Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - labetalol hcl - injection - 100 mg/20 ml - labetalol hcl 100 mg/20 ml

Canada - English - Health Canada

allergy canada ltd - allergenic extracts - liquid - 0unit - allergenic extracts 0unit - allergenic extracts

Canada - English - Health Canada

allergy canada ltd - allergen extract - diagnostic - liquid - 0unit - allergen extract - diagnostic 0unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extracts pollens - liquid - 40000unit - allergenic extracts pollens 40000unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extract non-pollen - solution - 40000unit - allergenic extract non-pollen 40000unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extract non-pollen - liquid - 40000unit - allergenic extract non-pollen 40000unit - allergenic extracts

Canada - English - Health Canada

omega laboratories limited - allergenic extract non-pollen - liquid - 40000unit - allergenic extract non-pollen 40000unit - allergenic extracts

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - poa pratensis, quantity: 20 %; anthoxanthum odoratum, quantity: 20 %; phleum pratense, quantity: 20 %; dactylis glomerata, quantity: 20 %; lolium perenne, quantity: 20 % - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.